ArticleEuropean heart journal. Cardiovascular pharmacotherapy2025
AZALEA-TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain.
Felice Gragnano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.